Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 January 2015 : Laboratory Research  

Up-Regulation of miR-9 Target CBX7 to Regulate Invasion Ability of Bladder Transitional Cell Carcinoma

Dalong XieAE, Chao ShangB, Hui ZhangC, Yan GuoD, Xiaojie TongAG

DOI: 10.12659/MSM.893232

Med Sci Monit 2015; 21:225-230

Abstract

BACKGROUND: Bladder urothelial carcinoma is the most common genitourinary system cancer in China. The objective of this study was to investigate whether the miR-9 can regulate the invasion ability of human bladder transitional cell carcinoma cells by down-regulation of CBX7.

MATERIAL AND METHODS: The expression of miR-9 was detected by quantitative real-time PCR in bladder transitional cell carcinomas (TCC) and normal bladder transitional cell (NBTC) samples. Bioinformatics software was used to predict some potential target genes of miR-9. T24 cells were transfected with pre-miR-9, and the CBX7 protein expression was detected by Western blot. Luciferase activities assay was selected to verify that CBX7 was a direct and specific gene of miR-9. T24 cells were transfected with pcDNA-CBX7, and the expression of CBX7 gene was detected. Then, the transwell assay was used to detect the invasion ability of T24 cells with CBX7 over-expression.

RESULTS: The expression of miR-9 increased significantly in human TCC specimens compared to that in NBTC specimens. TargetScan and PicTar software programs predicted CBX7 gene was a target gene of miR-9. The pre-miR-9 could up-regulate the miR-9 expression and down-regulate CBX7 protein expression. The luciferase activities assay verified that CBX7 gene was a direct and specific target gene of miR-9. The pcDNA-CBX7 transfection could up-regulate the CBX7 protein expression, and the invasion ability of T24 cells with CBX7 over-expression decreased significantly.

CONCLUSIONS: Aberrantly expressed miR-9 contributes to T24 cells invasion, partly through directly down-regulating CBX7 protein expression in TCC. This miRNA signature offers a new potential therapeutic target for TCC.

Keywords: Carcinoma, Transitional Cell - metabolism, Computational Biology, Polycomb Repressive Complex 1 - metabolism, Urinary Bladder - pathology, Urinary Bladder Neoplasms - pathology

Errate

Med Sci Monit 2020; 26:e924162     https://medscimonit.com/abstract/index/idArt/924162

The authors informed the journal that an error occurred in their manuscript.
The authors selected the wrong figure when uploading it due to the similarity of figures. They found this error when they were periodically sorting the experimental data and contacted the journal. This change does not affect the final results and conclusion.
Reference:
1. Dalong Xie, Chao Shang, Hui Zhang, Yan Guo, Xiaojie Tong: Upregulation of miR-9 Target CBX7 Regulates Invasion Ability of Bladder Transitional Cell Carcinoma. Med Sci Monit 2015; 21: 225-230. DOI: 10.12659/MSM.893232
 
Add Comment 0 Comments

Editorial

01 January 2025 : Editorial  

Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?

Dinah V. Parums

DOI: 10.12659/MSM.947707

Med Sci Monit 2025; 31:e947707

0:00

In Press

Clinical Research  

Factors Affecting Medication Adherence in Middle-Aged and Elderly Patients in China: A Cross-Sectional Study

Med Sci Monit In Press; DOI: 10.12659/MSM.945805  

Review article  

Characteristics and Associated Risk Factors of Broad Ligament Hernia: A Systematic Review

Med Sci Monit In Press; DOI: 10.12659/MSM.946710  

Clinical Research  

Cost-Effective Day Surgery for Arteriovenous Fistula Stenosis: A Viable Model for Hemodialysis Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.946128  

Clinical Research  

Impact of Periodontal Treatment on Early Rheumatoid Arthritis and the Role of Porphyromonas gingivalis Anti...

Med Sci Monit In Press; DOI: 10.12659/MSM.947146  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,963,777

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   700,314

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   23,719

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   18,460

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750